Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies.

Bo Ahrén; Chantal Mathieu; Giovanni Bader; Anja Schweizer; James E Foley

doi:10.1007/s00125-014-3222-z

Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies.

Bo Ahrén, Chantal Mathieu, Giovanni Bader, Anja Schweizer, James E Foley

Research output: Contribution to journal › Article › peer-review

731 Downloads (Pure)

Abstract

Randomised control trials (RCTs) do not always reflect real-life outcomes for glucose-lowering drugs. In this work we compared RCT and real-life data on the efficacy of the dipeptidyl peptidase-IV (DPP-4) inhibitor vildagliptin or sulfonylureas when added to metformin.

Original language	English
Pages (from-to)	1304-1307
Journal	Diabetologia
Volume	57
Issue number	7
DOIs	https://doi.org/10.1007/s00125-014-3222-z
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Subject classification (UKÄ)

Endocrinology and Diabetes

Access to Document

10.1007/s00125-014-3222-z

Springer__AhreIn_et_al

http://www.ncbi.nlm.nih.gov/pubmed/24682379?dopt=Abstract

Cite this

@article{5430aece631d4317b98c17bb40733af6,

title = "Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies.",

abstract = "Randomised control trials (RCTs) do not always reflect real-life outcomes for glucose-lowering drugs. In this work we compared RCT and real-life data on the efficacy of the dipeptidyl peptidase-IV (DPP-4) inhibitor vildagliptin or sulfonylureas when added to metformin.",

author = "Bo Ahr{\'e}n and Chantal Mathieu and Giovanni Bader and Anja Schweizer and Foley, \{James E\}",

year = "2014",

doi = "10.1007/s00125-014-3222-z",

language = "English",

volume = "57",

pages = "1304--1307",

journal = "Diabetologia",

issn = "1432-0428",

publisher = "Springer",

number = "7",

}

TY - JOUR

T1 - Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies.

AU - Ahrén, Bo

AU - Mathieu, Chantal

AU - Bader, Giovanni

AU - Schweizer, Anja

AU - Foley, James E

PY - 2014

Y1 - 2014

N2 - Randomised control trials (RCTs) do not always reflect real-life outcomes for glucose-lowering drugs. In this work we compared RCT and real-life data on the efficacy of the dipeptidyl peptidase-IV (DPP-4) inhibitor vildagliptin or sulfonylureas when added to metformin.

AB - Randomised control trials (RCTs) do not always reflect real-life outcomes for glucose-lowering drugs. In this work we compared RCT and real-life data on the efficacy of the dipeptidyl peptidase-IV (DPP-4) inhibitor vildagliptin or sulfonylureas when added to metformin.

UR - https://www.scopus.com/pages/publications/84903515239

U2 - 10.1007/s00125-014-3222-z

DO - 10.1007/s00125-014-3222-z

M3 - Article

SN - 1432-0428

VL - 57

SP - 1304

EP - 1307

JO - Diabetologia

JF - Diabetologia

IS - 7

ER -

Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies.

Abstract

UN SDGs

Subject classification (UKÄ)

Access to Document

Other files and links

Fingerprint

Cite this